Machine learning models classify the likelihood of developing Alzheimer's.

Published Date: 05 Apr 2023

A new study suggests that once adults reach age 65, the cutoff age for Alzheimer's disease onset, the extent of their genetic risk may outweigh age as a predictor of whether they will experience the fatal brain disorder.

Read Full News

Latest News

AHA Reframes Brain Health as a Lifelong Process

A new AHA scientific statement says sleep, mental health, pollution, and childhood adversity can shape cognitive aging and dementia risk, underscoring that brain health is built across a lifetime.

A Stepwise Approach Can Support Healthy Sleep in Children

Minimize the use of medications that counteract melatonin as well as stimulating activities that trigger cortisol, one researcher advised.

Roche Gets Second European Approval for Alzheimer's Test

Swiss drugmaker Roche has received the CE mark - a ⁠European regulatory clearance allowing sale in the region - for its second ⁠Elecsys blood test for Alzheimer's disease.

FDA Approves Ocrelizumab for Pediatric Relapsing MS

The FDA approval makes ocrelizumab a new treatment option for children aged 10 years and older with relapsing-remitting multiple sclerosis.

Multimodal Approach Can Manage Depression in Children

Psychotherapy is the intervention of first choice, and pharmacotherapy can be considered when psychotherapy alone is not effective, one psychiatrist says.

Decoding Spinal Muscular Atrophy (SMA): From Phenotypic Diversity to Early Diagnosis

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Latest News

A new AHA scientific statement says sleep, mental health, pollution, and childhood adversity can shape cognitive aging and dementia risk, underscoring that brain health is built across a lifetime.

Minimize the use of medications that counteract melatonin as well as stimulating activities that trigger cortisol, one researcher advised.

Swiss drugmaker Roche has received the CE mark - a ⁠European regulatory clearance allowing sale in the region - for its second ⁠Elecsys blood test for Alzheimer's disease.

The FDA approval makes ocrelizumab a new treatment option for children aged 10 years and older with relapsing-remitting multiple sclerosis.

Psychotherapy is the intervention of first choice, and pharmacotherapy can be considered when psychotherapy alone is not effective, one psychiatrist says.

Decoding Spinal Muscular Atrophy (SMA): From Phenotypic Diversity to Early Diagnosis

News All Time

Severe Malaria in Kids Linked to Certain Cognitive, Academic Deficits Years Later

Impairment persisted after episodes of cerebral malaria or severe malarial anemia

Rat Lungworm Is Now in My State. Is It in Yours Too?

The global, brain-invading parasite continues to spread

Suppressing a Sneeze May Have Led to Cerebrospinal Fluid Leak

While normally harmless, holding in a sneeze may in rare cases cause serious problems

Novel Agent Reduces Seizures in Treatment-Resistant Epilepsy

Adjunctive azetukalner cut monthly focal onset seizure frequency by 53% in phase III study

First Clinical Trial in MOGAD Meets Primary Endpoint

Satralizumab cuts relapse risk in myelin oligodendrocyte glycoprotein antibody-associated disease

Cemdisiran siRNA Therapy Demonstrates Efficacy in Myasthenia Gravis

Investigational treatment improves outcomes without complete complement blockade

Stiff Person Syndrome Patients Regain Mobility After Single-Dose Cell Therapy

CAR-T therapy shows promise in clinical trial

Cell Therapy Slows Upper Limb Decline in Duchenne Muscular Dystrophy

Investigational deramiocel is back under FDA review again

Real-World Registry Study Shows Alzheimer's Drug Safety Outcomes

No new signals for lecanemab emerged in ALZ-NET

CDC Study Reveals a Sleep-Deprived Nation

Women were more likely than men to have trouble falling and staying asleep

First-Time Seizures Linked to Higher Cancer Risk, Study Finds

Seizures may be a clue to non-neurologic cancer, not just brain tumors

Decoding Coffee-Dementia Links; Three Alzheimer's Trajectories; Mumps Encephalitis

News and commentary from the world of neurology and neuroscience

FDA Approves First Non-Antipsychotic Drug for Alzheimer's Agitation

Oral NMDA receptor antagonist gets an expanded indication

Study Examines if Prenatal Exposure to Sedatives Is Linked to Psych Disorders

South Korean study found no increased risk for 12 disorders among exposed offspring

New CDC Messaging May Be Eroding Trust in Vaccines, Survey Finds

Shift to uncertainty-based statements appears to increase vaccine hesitancy, according to study

Is Pure Autonomic Failure a Warning Sign for Parkinson's? What a New Study Shows.

High conversion rates to Parkinson's, dementia with Lewy bodies, or multiple system atrophy

Despite reports of hundreds of cancer cases, carcinogens have been discovered at nuclear missile sites in Montana.

New policy review highlights the importance of health-related quality of life in advanced cancer

Participate and win cash vouchers

Get updates on the latest events happening around the world

2.

The risk of ovarian cancer is not increased by salpingectomy, according to JAMA.

3.

Woman Loses 6-Year Battle With Mouth Tumor

4.

Shorter but More Intense RT: A Better Option for HNSCC?

5.

Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?

1.

The Science Behind Thrombolytic Drugs and Their Benefits

2.

Unlocking the Mystery of Elliptocytes: Exploring the Unusual Shape of Red Blood Cells

3.

MMA Embolization in Chronic Subdural Hematoma: Evidence, Outcomes, and Gaps

4.

Unlocking the Potential of Cancer Antigen 19-9 for Early Detection

5.

Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

2.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia

3.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Machine learning models classify the likelihood of developing Alzheimer's.

Latest News

AHA Reframes Brain Health as a Lifelong Process

A Stepwise Approach Can Support Healthy Sleep in Children

Roche Gets Second European Approval for Alzheimer's Test

FDA Approves Ocrelizumab for Pediatric Relapsing MS

Multimodal Approach Can Manage Depression in Children

Decoding Spinal Muscular Atrophy (SMA): From Phenotypic Diversity to Early Diagnosis

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

Latest News

News All Time

Severe Malaria in Kids Linked to Certain Cognitive, Academic Deficits Years Later

Rat Lungworm Is Now in My State. Is It in Yours Too?

Suppressing a Sneeze May Have Led to Cerebrospinal Fluid Leak

Novel Agent Reduces Seizures in Treatment-Resistant Epilepsy

First Clinical Trial in MOGAD Meets Primary Endpoint

Cemdisiran siRNA Therapy Demonstrates Efficacy in Myasthenia Gravis

Stiff Person Syndrome Patients Regain Mobility After Single-Dose Cell Therapy

Cell Therapy Slows Upper Limb Decline in Duchenne Muscular Dystrophy

Real-World Registry Study Shows Alzheimer's Drug Safety Outcomes

CDC Study Reveals a Sleep-Deprived Nation

First-Time Seizures Linked to Higher Cancer Risk, Study Finds

Decoding Coffee-Dementia Links; Three Alzheimer's Trajectories; Mumps Encephalitis

FDA Approves First Non-Antipsychotic Drug for Alzheimer's Agitation

Study Examines if Prenatal Exposure to Sedatives Is Linked to Psych Disorders

New CDC Messaging May Be Eroding Trust in Vaccines, Survey Finds

Is Pure Autonomic Failure a Warning Sign for Parkinson's? What a New Study Shows.

Recommended News For You

Breast Cancer Incidence Increased Due to Particulate Air Pollution, According to NIH Study.

Targeted Combination Shows Promise in Metastatic Kidney Cancer

Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.

Prostate cancer screening program beneficial in top decile of polygenic risk score

As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.

Despite reports of hundreds of cancer cases, carcinogens have been discovered at nuclear missile sites in Montana.

New policy review highlights the importance of health-related quality of life in advanced cancer

Recommended Articles For You

Hemoglobin C: Understanding its Role in Sickle Cell Disease

The Benefits of Understanding Haptoglobin High: What You Need to Know

Cold Antibody AIHA and Neoplastic Disorders: Unraveling the Clinical and Pathogenic Link

Demystifying Hematoma Rectus Sheath: Knowing the Symptoms and Causes

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Featured News

Featured Articles

Featured Events

Featured KOL Videos

Quick Links

Verification

Welcome to Hidoc Dr.